263 related articles for article (PubMed ID: 22786510)
1. Rheum officinale (a traditional Chinese medicine) for chronic kidney disease.
Wang H; Song H; Yue J; Li J; Hou YB; Deng JL
Cochrane Database Syst Rev; 2012 Jul; 2012(7):CD008000. PubMed ID: 22786510
[TBL] [Abstract][Full Text] [Related]
2. Oral adsorbents for preventing or delaying the progression of chronic kidney disease.
Wu HM; Sun HJ; Wang F; Yang M; Dong BR; Liu GJ
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD007861. PubMed ID: 25317905
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Effects of adding Rheum officinale to angiotensin-converting enzyme inhibitors or angiotensin receptor blockers on renal function in patients with chronic renal failure: A meta-analysis of randomized controlled trials
.
Yang Y; Ma YP; Zhang Z; Dai PL; Li P; Li WG
Clin Nephrol; 2018 Jun; 89(6):445-454. PubMed ID: 29208203
[TBL] [Abstract][Full Text] [Related]
5. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease.
Chung EY; Ruospo M; Natale P; Bolignano D; Navaneethan SD; Palmer SC; Strippoli GF
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD007004. PubMed ID: 33107592
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Sharma P; Blackburn RC; Parke CL; McCullough K; Marks A; Black C
Cochrane Database Syst Rev; 2011 Oct; (10):CD007751. PubMed ID: 21975774
[TBL] [Abstract][Full Text] [Related]
7. Aldosterone antagonists for preventing the progression of chronic kidney disease.
Bolignano D; Palmer SC; Navaneethan SD; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD007004. PubMed ID: 24782282
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.
Cooper TE; Teng C; Tunnicliffe DJ; Cashmore BA; Strippoli GF
Cochrane Database Syst Rev; 2023 Jul; 7(7):CD007751. PubMed ID: 37466151
[TBL] [Abstract][Full Text] [Related]
9. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Carpenter A; Dale-Harris I; Dorée C; Estcourt LJ
Cochrane Database Syst Rev; 2023 Aug; 8(8):CD012380. PubMed ID: 37539955
[TBL] [Abstract][Full Text] [Related]
10. Pentoxifylline for diabetic kidney disease.
Shan D; Wu HM; Yuan QY; Li J; Zhou RL; Liu GJ
Cochrane Database Syst Rev; 2012 Feb; (2):CD006800. PubMed ID: 22336824
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for preserving residual kidney function in peritoneal dialysis patients.
Zhang L; Zeng X; Fu P; Wu HM
Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009120. PubMed ID: 24953826
[TBL] [Abstract][Full Text] [Related]
12. Astragalus (a traditional Chinese medicine) for treating chronic kidney disease.
Zhang HW; Lin ZX; Xu C; Leung C; Chan LS
Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD008369. PubMed ID: 25335553
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone antagonists for preventing the progression of chronic kidney disease.
Navaneethan SD; Nigwekar SU; Sehgal AR; Strippoli GF
Cochrane Database Syst Rev; 2009 Jul; (3):CD007004. PubMed ID: 19588415
[TBL] [Abstract][Full Text] [Related]
14. Interventions for preventing the progression of autosomal dominant polycystic kidney disease.
Bolignano D; Palmer SC; Ruospo M; Zoccali C; Craig JC; Strippoli GF
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD010294. PubMed ID: 26171904
[TBL] [Abstract][Full Text] [Related]
15. Tripterygium wilfordii Hook F (a traditional Chinese medicine) for primary nephrotic syndrome.
Chen Y; Gong Z; Chen X; Tang L; Zhao X; Yuan Q; Cai G
Cochrane Database Syst Rev; 2013 Aug; (8):CD008568. PubMed ID: 23934958
[TBL] [Abstract][Full Text] [Related]
16. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
17. Dietary interventions for adults with chronic kidney disease.
Palmer SC; Maggo JK; Campbell KL; Craig JC; Johnson DW; Sutanto B; Ruospo M; Tong A; Strippoli GF
Cochrane Database Syst Rev; 2017 Apr; 4(4):CD011998. PubMed ID: 28434208
[TBL] [Abstract][Full Text] [Related]
18. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD001892. PubMed ID: 33118160
[TBL] [Abstract][Full Text] [Related]
19. Interventions for chronic kidney disease in people with sickle cell disease.
Roy NB; Fortin PM; Bull KR; Doree C; Trivella M; Hopewell S; Estcourt LJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012380. PubMed ID: 28672087
[TBL] [Abstract][Full Text] [Related]
20. Low protein diets for non-diabetic adults with chronic kidney disease.
Hahn D; Hodson EM; Fouque D
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD001892. PubMed ID: 30284724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]